1. Demographics, treatment patterns, safety, and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without rituximab: a retrospective study. (June 2013) Authors: Kolibaba, Kathryn S.; Sterchele, James A.; Joshi, Avani D.; Forsyth, Michael; Alwon, Erin; Beygi, Hooman; Kennealey, Gerard T. Journal: Therapeutic advances in hematology Issue: Volume 4:Number 3(2013) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis. Issue 6 (June 2014) Authors: Nordstrom, Beth L.; Knopf, Kevin B.; Teltsch, Dana Y.; Engle, Robert; Beygi, Hooman; Sterchele, James A. Journal: Leukemia & lymphoma Issue: Volume 55:Issue 6(2014:Jun.) Page Start: 1266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗